CAPLIN POINT LABORATORIES
|
The Current P/E Ratio of CAPLIN POINT LABORATORIES is 23.35.
Share Price | ₹1,357.0 | Apr 25,2024 |
Market Cap | ₹10,299.6 Cr | |
Earnings-TTM | ₹441.1 Cr | TTM-Consolidated Results |
Price/Earnings | 23.35x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CAPLIN POINT LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹10,299.6 Cr] as on Apr 25,2024
(/) Earnings [ ₹441.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 23.35x ]
Thus, for CAPLIN POINT LABORATORIES , the investors are currently willing to pay 23.35 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CAPLIN POINT LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CAPLIN POINT LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of CAPLIN POINT LABORATORIES
PE Ratio Performance Analysis for CAPLIN POINT LABORATORIES
- CAPLIN POINT LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 13.80x.
- CAPLIN POINT LABORATORIES 's operated at median p/e ratio of 12.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CAPLIN POINT LABORATORIES 's p/e ratio peaked in Mar2019 at 17.24x.
- CAPLIN POINT LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 9.93x.
How does CAPLIN POINT LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CAPLIN POINT LABORATORIES | 441.14 | 23.35 | 10,299.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.54 | 364,831.0 |
CIPLA LTD | 3,744.03 | 30.31 | 113,471.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.91 | 103,713.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.39 | 95,687.8 |
DIVIS LABORATORIES LTD | 1,382.97 | 73.73 | 101,960.0 |
MANKIND PHARMA LTD | 1,743.30 | 55.12 | 96,093.1 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 60.99 | 91,124.7 |
LUPIN LTD | 1,809.74 | 40.16 | 72,687.6 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.28 | 64,661.3 |
ABBOTT INDIA LTD | 1,145.58 | 47.60 | 54,533.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CAPLIN POINT LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.91x |
Max industry PE | 73.73x |
Median industry PE | 40.16x |
Average industry PE | 40.67x |
You may also like the below Video Courses